Chemoinformaics analysis of 6-Hydroxy-7- methoxylcoumarin
| Molecular Weight | 192.17 | nRot | 1 |
| Heavy Atom Molecular Weight | 184.106 | nRig | 12 |
| Exact Molecular Weight | 192.042 | nRing | 2 |
| Solubility: LogS | -2.206 | nHRing | 1 |
| Solubility: LogP | 1.186 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 22 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 1 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 10 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 11 |
| nHA | 4 | APOL | 25.2423 |
| nHD | 1 | BPOL | 12.3657 |
| QED | 0.695 |
| Synth | 2.05 |
| Natural Product Likeliness | 1.036 |
| NR-PPAR-gamma | 0.033 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.945 |
| HIA | 0.009 |
| CACO-2 | -4.727 |
| MDCK | 0.0000161 |
| BBB | 0.166 |
| PPB | 0.833588 |
| VDSS | 0.691 |
| FU | 0.194705 |
| CYP1A2-inh | 0.969 |
| CYP1A2-sub | 0.949 |
| CYP2c19-inh | 0.164 |
| CYP2c19-sub | 0.076 |
| CYP2c9-inh | 0.05 |
| CYP2c9-sub | 0.839 |
| CYP2d6-inh | 0.446 |
| CYP2d6-sub | 0.868 |
| CYP3a4-inh | 0.312 |
| CYP3a4-sub | 0.3 |
| CL | 13.326 |
| T12 | 0.837 |
| hERG | 0.097 |
| Ames | 0.061 |
| ROA | 0.068 |
| SkinSen | 0.563 |
| Carcinogencity | 0.602 |
| EI | 0.978 |
| Respiratory | 0.22 |
| NR-Aromatase | 0.071 |
| Antiviral | No |
| Prediction | 0.76216 |